Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P085: Epidemiology and results...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P085: Epidemiology and results of the first line therapy of HIV-related Hodgkin Lymphoma: Russian retrospective multicenter study

P085: Epidemiology and results of the first line therapy of HIV-related Hodgkin Lymphoma: Russian retrospective multicenter study

Bibliographic Details
Main Authors: Andrey Chekalov, Marina Popova, Ivan Tsygankov, Yuliya Rogacheva, Nikita Volkov, Anastasia Beynarovich, Kirill Lepik, Marina Demchenkova, Marina Grigorieva, Tatiana Schneider, Yuliya Kopeikina, Natalia Medvedeva, Ilya Zyuzgin, Elena Pavlyuchenko, Alexander Levanov, Alexander Myasnikov, Natalia Mikhailova, Vadim Baykov, Alexander Kulagin
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000890908.23632.87
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:2572-9241

Similar Items

  • P1077: HODGKIN LYMPHOMA IN PATIENTS WITH HIV: NATIONAL RETROSPECTIVE MULTICENTER STUDY
    by: A. Chekalov, et al.
    Published: (2022-06-01)
  • Epidemiology and results of the first line therapy for HIV-related Hodgkin lymphoma
    by: A. M. Chekalov, et al.
    Published: (2022-11-01)
  • PB2423: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIOR INFECTION CAUSED BY THE SARS-COV-2 (COVID-19)
    by: Aleksandr Siniaev, et al.
    Published: (2023-08-01)
  • P1179: PROGNOSIS OF PATIENTS WITH AGGRESSIVE REFRACTORY B-NHL TREATED WITH GLOFITAMAB IN REAL CLINICAL PRACTICE
    by: Liudmila Fedorova, et al.
    Published: (2023-08-01)
  • A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
    by: Kirill V. Lepik, et al.
    Published: (2020-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs